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Summary. Objectives: To assess the influence of maternal chorioamnionitis on early exhaled
nitric oxide (NO) and levels of nitrites–nitrates and interleukin (IL)-8 in endotracheal aspirate fluid in
mechanically ventilated preterm neonates. Study Design: Cross-sectional study. Patient–Subject
Selection: Between September 2007 and August 2009, 54 mechanically ventilated preterm
neonates were included. Patients were divided into two groups according to the presence or
absence of maternal chorioamnionitis, and those without chorioamnionitis (controls) were further
stratified into two subgroupsby birthweight<or2,000 g.Methodology: Theventilator usedwasa
Babylog 8000. The NO level assessed was the plateau value given by the software of the Sievers
NOA apparatus. Collection of endotracheal aspirate fluid samples was performed coinciding with
routine aspirations and using the dry technique. Results: The two groups of control neonates
showed statistically significant differences in exhaled NO expressed as nl/min and normalized
exhaled NO expressed as either nl/min or nl/min/kg, so they are not homogeneous and cannot be
used in clinical practice. Serum C-reactive protein and endotracheal aspirate levels of nitrites–
nitrateswere significantly higher in the chorioamnionitis group than in controls (3.6 vs. 1.07 mmol/L;
P ¼ 0.035). Nitrites–nitrates levels were positively correlated with exhaled NO in ppb (r ¼ 0.367;
P ¼ 0.006).Minute exhaled endogenousNOwas significantly higher in the chorioamnionitis group
(0.48 vs. 0.27 nl/min/kg; P ¼ 0.021). Conclusions: In mechanically ventilated preterm infants
weighing <2,000 g, maternal chorioamnionitis was associated with an increase of early exhaled
NO (nl/min/kg) and serum levels of C-reactive protein and levels of nitrites–nitrates in endotracheal
aspirate fluid. Pediatr Pulmonol. 2011; 46:595–603.  2011 Wiley-Liss, Inc.
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INTRODUCTION
Maternal chorioamnionitis may cause preterm delivery
and be associated with an adverse perinatal outcome,
including early-onset sepsis, necrotizing enterocolitis,
and lung disease as well as long-term sequelae in the
infant.1–4 Histologic chorioamnionitis is associated with
an increased incidence of bronchopulmonary dysplasia
(BPD),5 a chronic lung disease that prolongs hospital stay
and causes greater morbidity and mortality of respiratory
origin.6–9
Chorioamnionitis may injure the fetal lung through the
activation of alveolar neutrophils and macrophages. Due
to this activation, greater expression of inducible nitric
oxide (NO) synthase is to be expected, with elevation
of nitrites and nitrates in endotracheal aspirates and of
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minute exhaled NO. Exhaled NO is raised in adults and
children with asthma,10,11 and has also been detected
among the gases exhaled in mechanically ventilated neo-
nates.12–17 Different results of exhaled NO in neonates
with BPD have been reported, including lower values in
infants breathing spontaneously18 and higher exhaled NO
peak levels inventilated infants.19 Differences in postnatal
age16–19 and in the methods for assessing exhaled NO
(breathing spontaneously or on assisted ventilation,6,18
output or minute ventilation obtained using plateau NO
values,18 or peak or maximum values of exhaled NO19)
may account for the conflicting results. Although recom-
mendations concerning standardized techniques for
measurement of exhaled NO have been reported,20 data
for analysis of exhaled NO in mechanically ventilated
preterm infants are lacking. Williams et al.21 studied
the influence of ventilatory settings on measurements of
exhaled NO and found that increasing peak inflating pres-
sure as well as the inspired oxygen concentration resulted
in a decrease in the peak NO levels. The authors empha-
sized that the conditions of measurement must be stand-
ardized in infants receiving respiratory support. In a
previous study of our group,22 the following points were
suggested when collecting gas samples from ventilated
premature infants to obtain exhaled NO: (1) it would
suffice to collect exhaled gas during 1 min, although it
is recommended to repeat collection three times;15 (2)
for each sample collection, the parameters to record
should be fraction of inspiratory oxygen (FiO2), peak
inspiratory pressure (PIP), positive end expiratory pres-
sure (PEEP), respiratory frequency (RF), I/E, volume/
minute, and percentage of leakage (the two latter ones,
every 15 sec during collection); and (3) the results should
be expressed as exhaled NO (ppb plateau value), ‘‘minute
exhaled NO/kg after correction for leakage’’ (exhaled
NO  volume/min/weight in kg ¼ nl or ppb/min/kg)
and ‘‘normalized minute exhaled NO/kg after correc-
tion for leakage’’ (after applying the normalization
equation).22
The cellular composition of tracheal aspirate is the gold
standard for defining lung inflammation.23 Interleukin-8
(IL-8) is produced by alveolar macrophages, fibroblasts,
type II pneumocytes, and endothelial cells. Hypoxia,
hyperoxia, and endotoxins stimulate the synthesis of
IL-8, which is a major neutrophil chemotactic factor in
the lung.Histologic chorioamnionitis is associatedwith an
increase of IL-8 in endotracheal aspirate fluid along the
first day of life (917 pg/ml) and this cutpoint may be
used for diagnosis.24 Preterm infants suffering from
BPD can present increased levels of tumor necrosis alpha
(TNF-alfa),25 IL-6,25 IL-8,26 and IL-1026 in endotracheal
aspirates.
The present study was designed to assess changes of
early exhaledNOand the concentration of nitrites–nitrates
and IL-8 in endotracheal aspirate fluid in mechanically
ventilated preterm neonates with and without history of
maternal chorioamnionitis.
MATERIALS AND METHODS
Design and Patient Population
A cross-sectional study of mechanically ventilated pre-
term infants was conducted to assess the impact of cho-
rioamnionitis on exhaled NO and the concentration of
nitrites–nitrates and IL-8 in endotracheal aspirates.
Between September 2007 and August 2009, 54 mechan-
ically ventilated preterm neonates treated in the
Neonatology Service of a IIIB level neonatal intensive
care unit were eligible. Inclusion criteria were gestational
age between 25weeks 0 days and 36weeks 6 days,<36 hr
of age, presence of mechanical ventilation for the treat-
ment of respiratory distress syndrome (RDS), hemody-
namic stability, and written informed consent obtained
from the parents or legal guardians. Newborns with pul-
monary hypoplasia or other respiratory conditions other
thanRDS,major congenital malformations, chromosomal
abnormalities, sepsis, or treatment with NO donor drugs
were excluded. Patients were divided into two groups
according to the presence or absence of maternal cho-
rioamnionitis, and those without history of chorioamnio-
nitis (controls) were further stratified into two subgroups
according to birth weight <2,000 g or 2,000 g. The
study protocol was approved by the Ethics Committee
of Hospital Clinic of Barcelona, Spain. The parents or
legal guardians were informed about the study and pro-
vided consent because no blood sampling was needed and
procedures performed were not painful and were included
in the care of the patients (tracheal aspirates).
Definitions and Procedures
The diagnosis of clinical chorioamnionitis in the
pregnant woman who presented with premature labor or
premature rupture of the membranes was made in the
presence of some combination of uterine pain, fever
(388C), leukocytosis (>12,000 cells/mm3), and increased
serum concentrations of C-reactive protein (>30 mg/L)
without any clear focus of infection. In these cases, amni-
otic fluid and placenta were microbiologically cultured,
and placenta and umbilical cord histologically analyzed.
Chorioamnionitis was diagnosed when clinical data were
accompanied by a positive culture from amniotic fluid and
placenta (fetal and maternal sites) and histological find-
ings of chorioamnionitis. Polymorphonuclear infiltration
in the placenta and umbilical cord was required to estab-
lish a diagnosis of histological chorioamnionitis. Mild
chorioamnionitis had a few neutrophils (5–10 neutrophils
per high-power field) scattered in the subchorionic space
and adjacent chorion; moderate chorioamnionitis had
many neutrophils (11–30 neutrophils per high-power
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field) in the lower half of the chorionic plate and the
subchorionic space; and severe chorioamnionitis had
dense infiltrates of neutrophils (30 per high-power field)
throughout the chorionic plate into the amnion. Mild
chorioamnionitis was recorded in seven cases, moderate
in three, and severe in five.
RDS was defined in the presence of a typical clinical
course and chest radiographic findings, with clinical
improvement when exogenous surfactant was adminis-
tered. RDS was considered non-severe if only one dose of
exogenous surfactant was needed and severe if two or
more doses of exogenous surfactant or high-frequency
oscillatory ventilation were needed as well as in the pres-
ence of air leak or if RDSwas the cause of death. BPDwas
defined according to diagnostic criteria of Jobe and
Bancalari.27
At all times, neonates received appropriatemedical care
according to his/her clinical condition. Special attention
was placed to maintain the inspired gas temperature at
378Candmaximumhumidity of the circuit (100%) using a
Fisher–Paykel humidifier. Serial measurements of heart
rate, RF, non-invasive blood pressure, and arterial blood
gases were performed. Ventilatory parameters included
PIP, PEEP, inspiratory time (Ti), effectiveRF, tidal volume
(Vt), minute volume (Vm), and compliance (A). The
Clinical Risk Index for Babies (CRIB) score (in infants
weighing <1,500 g) and the Score for Neonatal Acute
Physiology (SNAP) and SNAP Perinatal Extension
(SNAPPE II) score were assessed to check homogeneity
of the patients’ severity of illness.
All infants were mechanically ventilated using a con-
stant flow, time cycled, pressure-limited device (Babylog
8000 Plus, Dräger Medical AG & Co. KGaA, Lübeck,
Germany), which measures all ventilatory parameters
displayed in the screen of the device during the expiratory
time. Oxygenation was continuously monitored by pulse
oximetry to maintain arterial blood oxygen saturation
(SaO2) between 88% and 93% and arterial partial pressure
(PaO2) between 50 and 80 mmHg. For ventilation, we
tried to achieve carbon dioxide partial pressure (PaCO2)
in the range of 45–55 mmHg and pH >7.20 during the
first 96 hr; then, high PaCO2 levels were allowed while
maintaining pH >7.20. In order to avoid share stress-
induced release of NO from vascular endothelium,28
gentle ventilation was used.
All newborns were intubated with a double-lumen
endotracheal tube (inner diameter 2.7 and 3.2 mm in
infants weighing 600–900 g and 1,000–1,500 g, respect-
ively) if a deep resuscitation was needed in the delivery
room, or when a FiO2 >0.30 was required, or in the
presence of moderate, severe, or progressive respiratory
difficulty in spite of receiving continuous positive
airway pressure (CPAP) of 6 cm water. All intubated
infants received surfactant (Survanta, Ross Laboratories,
Columbus, OH) at 4 ml/kg (100 mg of phospholipids/
kg), which was repeated if needed. Initial ventilatory
setting included flow 5–8 L/min, PEEP 5 cm H2O,
RF 60 breaths/min, and FiO2 to keep SaO2 in the range
of 88–93%. Thereafter, PIP and RFwere adjusted to reach
the aforementioned pH and PaCO2 levels. Sedation was
not routinely used during the study.
NO Sampling
The sample of gas for NO analysis was obtained taking
into account that no exogenous surfactant was adminis-
tered in the previous 6 hr and in the presence of correct
humidification of the circuit, correct calibration of the NO
apparatus (chemiluminescence technique), and low pro-
portion of NO (<40 ppb) in the compressed wall air. NO
sampling was performed as previously described22 and
trying to standardize the ventilation parameters21
(FiO2 ¼ 0.21, RF ¼ 50 respirations/min, Ti ¼ 0.4 sec,
PIP ¼ 20 cm water, PEER ¼ 5 cm water) during the
3 min of NO sampling. This change in the ventilation
parameters was well tolerated and in only 12 cases we
had to increase FiO2 to<0.35. The sample of gas in which
NO was analyzed was obtained through a ‘‘6 French’’
arterial catheter introduced into the endotracheal tube to
its tip. This catheter is the narrowest that permits adequate
aspiration of the gas samplewithout generating an alarm in
the Sievers NOA apparatus. Furthermore it occupies very
little of the endotracheal cross-sectional area, and hence
does not affect ventilation of the lung. Three samples of
gas during 1 min each were obtained. The mean intra-
subject coefficient of variability of exhaled NO levels (in
ppb) was calculated from the mean of three 1-min
sampling periods in each of the 54 infants. The coefficient
of variation was 12.7%.
Influence of Air Contamination
The absence of environmental air contamination in
exhaled NO samples was confirmed by the lack of corre-
lation between ambient NO and exhaled NO in ppb
(n ¼ 54, r ¼ 0.35, P ¼ 0.802) as well as between
inhaled NO and exhaled NO in ppb (n ¼ 54,
r ¼ 0.176, P ¼ 0.203). The mean (standard deviation,
SD) inspired NO level was 1.27 (0.91) ppb (range 0–4.1).
Calculation of Plateau NO and Minute Exhaled NO
TheNO level assessed is not the highest peak, but rather
the plateau value given by the software of the SieversNOA
apparatus. This plateau value is the most reliable equiv-
alent of the NO exhaled during expiration (corresponding
to the average NO detected between 1/2 and 7/8 of the
duration of expiration). Sievers NOA 280i is able to detect
from 0.5 ppb to 500 ppm of NO, with a sensitivity of
0.5 ppb, aspirating a gas sample of 10–200 ml/min
(100 ml/min in our study) and with a lag time of 1 sec
and an electronics response time of 0.067 sec (sampling
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rate of 15 Hz) to 90% full scale. This high speedmeans the
apparatus can differentiate between inspired gas (contami-
nated with compressed air) and expired gas, which adopts
the form of a plateau. Minute exhaled NO or minute
excretion of NO was calculated using the formula:
V0NOðnl=minÞ ¼ Plateau NO ðppb ¼ nl=LÞ
 VEðminute ventilation in L=minÞ
VE has been previously corrected by the percentage of
leakage given by the software of the Babylog 8000 venti-
lator using the formula:
VEðL=minÞ ¼ Volume per minuteðL=minÞð100leakageÞ=100
Finally, minute exhaled NO was divided by the weight
in kilograms of the newborn to obtain the minute exhaled
NO/kg (nl/min/kg). To convert nl to nmol, it should be
remembered that 1 mol ¼ 24.3 L, when environmental
temperature is 238C.
The results can be normalized by applying the
formula developed in a previous report22 as follows:
Normalized minute exhaled NO ¼ minute exhaled NO
without leakage  minute exhaled NO deviation, being
minute exhaled NO deviation ¼ 173.668  (exhaled
NO/100)3 þ 49.513  (exhaled NO/100) þ 12.486 
(VM/100)3 þ 24.075 (PIP/100)þ 12.371 (RF/100)3 
8.126  average minute exhaled NO.
Collection of Endotracheal Aspirate Fluid Samples
Collection of endotracheal aspirate fluid samples
was performed before the administration of exogenous
surfactant or at least 6 hr later29 coinciding with routine
aspirations and according to the dry technique, which
for research purposes is equally valid than the bronchoal-
veolar lavage.30 To obtain the mucus aspirated inside
the catheter, the catheter was cleaned with 1 ml of normal
saline into a tube and finally purged with air. The entire
procedure was repeated to have a 2 ml sample, 1 ml of
which was placed in another tube for nitrites–nitrates
analysis. Moreover, 1 ml of the same normal saline was
placed in another tube as it may be contaminated by
different amounts of nitrites–nitrates. Likewise, 0.2 ml
for analysis of IL-8 and 0.2 ml for analysis of proteins
were also kept. The diluted endotracheal aspirate fluid
samples were centrifuged and the supernatant was
recovered and frozen at 808C, as the tube with normal
saline only. Samples were delivered to the laboratory
on ice.
Measurement of Nitrites–Nitrates, IL-8, and Protein
Levels in Endotracheal Aspirates
The concentration of nitrites–nitrates in endotracheal
aspirateswasmeasured by amodification of the fluorimetric
technique based on the reaction between 2,3-diamino-
naphthalene and nitrites in acid medium. Previous filtra-
tion in Ultrafee column (UFC4 LGC, Millipore Corp.,
Bedford, MA) is needed to avoid interferences with
serum components. The detection limit of the technique
is 0.01–50 mmol/L.Resultswere expressed inmmol/L and
in relation to the concentration of proteins. Levels of IL-8
were measured by a highly sensitive ELISA technique
(Diasource Systems) and results were expressed as pg/ml
and in relation to the concentration of proteins. Proteins
were measured by an automated method to normalize
nitrites–nitrates and IL-8 concentrations per gram of
proteins in the endotracheal aspirate fluid, so that errors
related to differences in the amount of collected samples
were avoided.
Variables
In all infants and before the 36 hr of life, the following
variableswere recorded: gestational age, sex, birthweight,
hours of life, history of maternal chorioamnionitis,
maternal smoking during pregnancy, cesarean section,
severity of illness (CRIB and SNAPPE-II score), concom-
itant diseases, such as severe RDS, air leak, patent ductus
arteriosus, severe periintraventricular hemorrhage (grades
3–4), early sepsis, early exhaled NO (minute exhaled NO/
kg [expressed as nl/min/kg], actual and normalized
value),22 and concentrations of nitrites–nitrates (mmol/L
andmmol/g proteins) and IL-8 (pg/ml and pg/g proteins) in
the endotracheal aspirate fluid.
Statistical Analysis
Continuous variables were presented as mean  SD
if normally distributed and with homogeneous variances
or as median and interquartile range (IQR: 25th to
75th percentiles) if not normally distributed or without
homogeneous variances. These latter variables were birth
weight; C-reactive protein levels; nitrites–nitrates, IL-8,
and protein levels in endotracheal aspirates; duration of
supplemental oxygen therapy; and all exhaled NO
measurements. The influence of environmental NO or
NO in compressed air on exhaled NO was analyzed by
means of Spearman correlation, as well as other corre-
lations between exhaled NO and other variables, particu-
larly levels of nitrites–nitrates and IL-8 in endotracheal
aspirates, and days of supplemental oxygen therapy. The
Student’s t-test was used for the comparison of parametric
variables and the Mann–Whitney U-test for the compari-
son of non-parametric variables among the different
groups according to ‘‘maternal chorioamnionitis’’ (yes/
no). Infants with and without history of maternal
chorioamnionitis were matched by birth weight.
Categorical variables were compared with the chi-square
(x2) test or the Fisher’s exact test. To determine the most
useful cut-point of exhaled NO as a marker of history
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of chorioamnionitis, the value with the best relation
sensitivity–specificity and the highest positive likelihood




As shown inTable 1, the two groups of neonateswithout
history of maternal chorioamnionitis showed statistically
significant differences in the use of antenatal steroids,
gestational age, birth weight, and Apgar score at 5 min
after birth. In addition (Table 2), there were significant
differences in exhaled NO expressed as nl/min and nor-
malized exhaled NO expressed as either nl/min or nl/min/
kg. Therefore, the two subgroups were not homogeneous,
and the most similar to the study group was the subgroup
with <2,000 g of birth weight. This subgroup will be
considered the control group.
Comparison of Infants With and Without History of
Maternal Chorioamnionitis
Clinical findings and morbidity according to history of
maternal chorioamnionitis are shown in Table 1. Preterm
newborns in the chorioamnionitis group compared with
controls weighing <2,000 g were less frequently born by
cesarean section and mothers were older. Moreover, a
significantly higher percentage of infants with history
of maternal chorioamnionitis needed resuscitation and
endotracheal intubation more frequently and presented
with patent ductus arteriosus or severe intraventricular
hemorrhage. The only newborn who died from the cho-
rioamnionitis group was a 25 weeks’ preterm infant with a




(groups 1 vs. 2)
P-value
(groups 2 vs. 3)
Absent
Present
(group 3)2,000 g (group 1) <2,000 g (group 2)
Total infants 13 26 15
Mother and labor
Age, years, mean (SD) 32.8 (3.9) 30.0 (3.9) 33.8 (4.8) 0.185 0.039
Smoking during pregnancy 0 6 (23.0) 0 0.158 0.120
Antibiotic treatment 9 (69.2) 15 (62.5) 13 (92.9) 0.734 0.059
Antenatal steroids 4 (30.8) 22 (84.6) 14 (93.3) 0.003 0.411
Inborn 8 (61.5) 22 (84.6) 15 (100) 0.129 0.278
Cesarean section 8 (61.5) 19 (73.1) 5 (33.3) 0.486 0.012
Multiple gestation 3 (23.1) 11 (42.3) 7 (46.7) 0.409 0.786
Newborns
Hours of life, mean (SD) 21.8 (8.6) 21.5 (7.3) 17.1 (7.9) 0.997 0.224
Male 10 (76.9) 13 (50) 8 (53.3) 0.112 0.839
Gestational age, weeks, mean (SD) 34.1 (1.6) 29.2 (2.4) 28.1 (2.7) 0.000 0.386
Birth weight, median (IQR) 2,200 (2,160–2,610) 1,020 (970–1,400) 1,100 (850–1,360) 0.000 0.968
Intrauterine growth restriction 0 3 (11.5) 0 0.524 0.457
Resuscitation (endotracheal tube) 0 7 (26.9) 9 (60) 0.105 0.037
Apgar score at 5 min, mean (SD) 9.8 (0.4) 8.0 (1.7) 8.1 (1.5) 0.003 0.959
CRIB score1, mean (SD) 2.5 (2.3) 2.8 (1.8) 0.746
SNAPPE II score, mean (SD) 11.8 (9.1) 21.5 (13.4) 23.7 (15.9) 0.110 0.885
Morbidity
Severe respiratory distress syndrome 9 (69.2) 15 (57.7) 11 (73.3) 0.491 0.323
Pneumothorax 0 1 (3.8) 2 (13.3) 0.999 0.543
Patent ductus arteriosus 3 (23.1) 8 (30.8) 10 (66.7) 0.719 0.028
Intraventricular hemorrhage (grades 3–4) 0 0 4 (26.7) 0.013
Early-onset sepsis 0 0 2 (13.3) 0.128
Late-onset sepsis 0 2 (7.7) 3 (20) 0.544 0.336
Necrotizing enterocolitis 0 2 (7.7) 1 (6.7) 0.544 0.999
Supplemental oxygen, days, median (IQR) 2 (1–4) 3 (1–15) 3 (1.5–8.5) 0.208 0.883
Bronchopulmonary dysplasia 0 6 (23.1) 3 (20) 0.081 0.999
Retinopathy of prematurity 0 4 (15.4) 4 (26.7) 0.281 0.434
Deaths 0 1 (3.8) 1 (6.7) 0.999 0.999
IQR, interquartile range (25th to 75th percentile).
Data as absolute numbers and percentages in parenthesis unless otherwise stated.
1In infants weighing <1,500 g.
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birth weight of 810 g and a CRIB score of 4, who was
intubated only during the first day of life after receiving
two doses of surfactant. Seven days after birth he suffered
from necrotizing enterocolitis with intestinal perforation
and died. The only newborn who died from the control
group was a 25 weeks’ preterm infant with a birth weight
of 740 g and a CRIB score of 4, who developed a very
severe BPD and died 49 days after birth.
The values of inflammatory markers and exhaled NO
according to history of maternal chorioamnionitis are
shown in Table 2. C-reactive protein was higher in the
chorioamnionitis group. IL-8 levels, either in absolute
values or divided by the protein content of the endotra-
cheal aspirate were also higher in this group, although
statistically significant differences were not reached.
However, the levels of nitrites–nitrates were significantly
higher than in controls (P ¼ 0.035) and were positively
associated with exhaled NO in ppb (n ¼ 54, r ¼ 0.367,
P ¼ 0.006).
Minute exhaled endogenous NO, expressed in nl/min/
kg, was significantly higher in the chorioamnionitis group.
The most useful cutoff for exhaled NO as a marker of
history of maternal chorioamnionitis was 0.285 nl/min/
kg, with a sensitivity of 73.3%, specificity of 57.7%,
positive predictive value of 50.0%, negative predictive
value of 78.9%, accuracy of 63.4%, positive likelihood
ratio of 1.733, negative likelihood ratio of 0.462, and area
under the curve of 0.718 (P ¼ 0.021).
Peak values of exhaled NO were significantly higher in
the chorioamnionitis group than in controls (P ¼ 0.032)
and also showed a significant correlation with nitrites–
nitrates levels in the endotracheal aspirate fluid (n ¼ 54,
r ¼ 0.322, P ¼ 0.018).
DISCUSSION
In the healthy newborn, exhaled NO is not affected by
the gestational age,13,16,29,31,32 birth weight,33 or mode of
delivery,29 although there is an increase in exhaled NO
during the first week of life.16,29 Exhaled NO is not related
either with serum levels of nitrites and nitrates,13,24
but there may be a relationship with nitrites and nitrates
that are present in the low respiratory tract.33 In addition,
there are two trends in the publications of research
groups working on expired or exhaled NO in newborns:
those authors who work only with concentrations
(ppb)6,12–14,16,17,34 and those as our group who prefer to
adapt the methodologies to present the results as ‘‘total
excretion of exhaled NO’’ (nl/min/kg).17,29,31,32,35,36
Olsen et al.15 in 2003, measured exhaled NO in eight
preterm infants with RDS and showed a decline of median
minute excretion of NO by 48–72 hr. Williams et al.16
measured nasal and lower airway NO level in very imma-
ture infants (median gestational age 27 weeks) and found
that nasal and lower airway NO levels did not correlate
significantly with gestational age, but lower airway NO
levels correlated with postnatal age.
As far as we are aware, the relationship between
maternal chorioamnionitis and possible increases in
nitrites–nitrates levels in endotracheal aspirates and





(groups 1 vs. 2)
P-value
(groups 2 vs. 3)
Absent
Present
(group 3)2,000 g (group 1) <2,000 g (group 2)
Total infants 13 26 15
Inflammatory markers
C-reactive protein <24 hr life, mg/L 0 (0–0) 0 (0–1) 1 (0–10.5) 0.508 0.035
C-reactive protein <48 hr life, mg/L 3 (1–13) 2 (1–3) 9 (1–25.5) 0.738 0.140
Nitrites–nitrates, mmol/L 2.4 (0.75–4.0) 1.1 (0.6–2.2) 3.6 (1.1–5.1) 0.178 0.035
IL-8, pg/ml 477 (135–5,660) 497 (191–1,181) 1,161 (241–2,485) 0.627 0.277
Proteins, mg/dl 0.25 (0.08–0.46) 0.21 (0.11–0.39) 0.29 (0.19–044) 0.879 0.192
Nitrites–nitrates, mmol/L/g proteins 17.9 (4.6–31.5) 6.1 (1.6–15.4) 11.8 (8.0–17.5) 0.178 0.222
IL-8, pg/ml/g protein 2,769 (1,871–25,381) 3,032 (351–10,964) 5,918 (1,116–12,148) 0.259 0.619
Exhaled NO, expressed as
ppb 1.48 (0.90–1.96) 1.03 (0.56–1.78) 1.33 (1.01–2.89) 0.308 0.056
nl/min 0.71 (0.38–0.91) 0.32 (0.18–0.47) 0.46 (0.28–0.92) 0.007 Not calculated1
nl/min/kg 0.30 (0.17–0.41) 0.27 (0.16–0.48) 0.48 (0.27–0.77) 0.670 0.021
Normalized exhaled NO, expressed as
nl/min 1.23 (0.71–1.41) 1.48 (1.26–1.55) 1.55 (1.52–1.62) 0.038 Not calculated1
nl/min/kg 0.45 (0.33–0.57) 1.22 (0.92–1.54) 1.54 (1.13–1.79) 0.000 Not calculated1
Peak of exhaled NO, ppb 2.24 (1.69–2.50) 1.72 (1.07–2.41) 2.14 (1.62–4.29) 0.159 0.032
Data as median an interquartile range (IQR, 25th to 75th percentile).
1Because of lack of homogeneity of the control group (i.e., statistically significant differences between groups 1 and 2).
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exhaled NO during the first days of life have not been
previously investigated. In the present study, these
parameters were examined exclusively in mechanically
ventilated preterm infants with RDS. The increase of
plateau and peak exhaledNOand their positive correlation
with endotracheal nitrites–nitrates suggest that both fac-
tors are related and due to the same inflammatory process.
It has been shown that nitrate concentration in bronchoal-
veolar lavage fluid is elevated in infants who developed
chronic lung disease of prematurity.33 In the present study,
mean IL-8 values were higher in the chorioamnionitis
group than in the control group (1,161 vs. 497 pg/ml),
although differences were not statistically significant
(P ¼ 0.277), probably because of the high dispersion of
values. It is likely that changes in IL-8 would have been
more apparent with a larger sample size.
The birthweight cutoff point of 2,000 gwas empirically
chosen in an attempt to homogenize the sample in order to
analyze the results of exhaled NO in different forms
(including ppb, nl/min, nl/min/kg, and normalized val-
ues). It was observed that plateau exhaledNO expressed in
nl/min was significantly different between the two control
subgroups; therefore, this measurement is not useful in
clinical practice. The same findings were observed for
normalized plateau exhaledNO expressed as either nl/min
or nl/min/kg. A comparison of the chorioamnionitis group
with the control subgroup of <2,000 g seems reasonable
as both groups were homogeneous regarding gestational
age and birthweight. However, if comparisonswould have
been performedwith the 15 infants in the chorioamnionitis
group and all 39 controls, heterogeneity of controls would
probably account for the disappearance of statistically
significant differences for nitrites–nitrates (mmol/L) and
peak of exhaled NO (ppb) between infants in the cho-
rioamnionitis and controls of<2,000 g. In fact, a positive
aspect of the present study was the stratification of
infants in the control group according to birth weight,
which allowed comparing infants in the chorioamnionitis
group with only those preterm babies without history of
chorioamnionitis and similar features of immaturity and
birth weight. This stratification also revealed that in con-
trols, the expression of exhaled NO in nl/min, both in
actual and normalized values was not homogeneous.
When exhaled NO was expressed according to the birth
weight, actual values of exhaled NO appeared homo-
geneous, in contrast with normalized values which are
even spread out more. Therefore, the attempt to normalize
exhaled NO reported in a previous study,22 unfortunately
is not useful in clinical practice. In this respect, plateau of
exhaled NO in ppb and nl/min/kg and peak of exhaled
NO in ppb seem to be the only useful parameters in clinical
practice. Another positive aspect was the absence of
subclinical chorioamnionitis in the control group, because
in that group the histology of the placenta had to be
normal.
The present findings should be interpreted taking into
account some limitations of the study, particularly the
exclusion of perinatal sepsis; in this case, marked
increases in endogenous NO with secondary increase of
exhaled NO have been reported.37 In addition, the study
was restricted to the first 36 hr of life, and may be there-
after other results would be obtained.
One difficulty when attempting to analyze exhaled NO
of bronchoalveolar origin is the risk that the determination
could be invalidated due to NO contained in the gas
inhaled. This is not the case when using the ‘‘breath
program’’ software which accompanies the Sievers
NitricOxideAnalyzer (NOA280i) in themode designated
‘‘use pressure for breath detection mode,’’ and with ‘‘on-
line sampling.’’ It is considered that the gas in the region
between 1/2 and 7/8 of the duration of expiration is
equivalent to the third and fourth quartiles of the expira-
tion time, when the gas obtained is exclusively bronchoal-
veolar,38 with no possibility of external contamination.
The manufacturers of the NOA 280i only recommend the
use of medicinal air (NO-free) when environmental NO
levels exceed 40–50 ppb. Our compressed air NO levels
never reached these values (range 0–4.1 ppb). For
repeated measurements of exhaled NO in each expiration,
it should be available a chemiluminescence analyzer of
rapid response (0.2 sec) and at a flow rate of >1.7 ml/
sec (Sievers NO analyzer [NOA 280] with a response time
of 0.2 sec and a minimum sample of 100–300 ml/min).
In our previous study,22 it was shown that the variable
volume per minute was highly influenced by the percent-
age of leakage given by the ventilator. Although the
leakage of gas around the endotracheal tube is low, the
sample of gas aspirated by the analyzer is considered as a
leak by the ventilator. This leakage can be corrected
mathematically, and indeed this should always be done.
Therefore, in the present study minute exhaled NO was
obtained multiplying the plateau NO value (plateau
between 1/2 and 7/8 of expiration) by the volume per
minute, as Olsen et al.15 have previously reported, but
volume per minute was previously corrected by the per-
centage of leakage.
In the present study, exhaled NO obtained at the trache-
obronchial level and during the expiratory phase was
expressed as total exhaled NO in nl/min/kg, and this value
was also normalized according to setting of ventilation
parameters.22Medianvalues of exhaledNOwere 0.48 and
0.27 nl/min/kg in infants with and without history of
maternal chorioamnionitis, respectively. These figures
are similar to those reported by Olsen et al.15 who showed
that minute excretion of NO (divided by the weight) in
premature infants with RDS and mechanically ventilated
at 24 hr of life was 0.405 nl/min/kg. In our group of
chorioamnionitis, higher values of exhaled NO in nl/
min/kg were found. A value of exhaled NO >0.285 nl/
min/kg would be suggestive of history of maternal
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chorioamnionitis with a 50% positive predictive value.
This low figure and the fact that exhaled NO should be
measured in the postnatal period preclude the clinical use
of this parameter as a diagnostic criterion of chorioam-
nionitis. The increase in exhaled NO in nl/min/kg and in
nitrites–nitrates levels in the endotracheal aspirate fluid,
and the positive correlation between both parameters,
would support the common origin of NO in the lower
respiratory airway as a result of the inflammatory process.
On the other hand, a significant higher incidence ofBPD
in the chorioamnionitis groups was not observed, which
may be explained by the use of antibiotic treatment and
antenatal corticoids for fetal maturation, all of which
attenuates the inflammatory process.39 Lahra et al.40 even
suggested that fetal inflammatory response during cho-
rioamnionitis is a protective factor for chronic lung dis-
ease. May et al.41 reported the peak exhaled NO values
obtained on days 3, 5, 7, 14, 21, and 28 after birth in 80
preterm infants of <32 weeks of gestation, depending on
the appearance of BPD. In the 20 preterm infants who did
not develop BPD, mean (SD) peak exhaled NO level at
3 days was 4.8 (2.5) ppb. In our study, mean peak exhaled
NO level in the chorioamnionitis group was 2.14 ppb
(range 1.62–4.29), which is somewhat lower. This may
be due to age differences at the time of sampling (mean
17.1 hr in our study and 3 days in the study ofMay et al.41).
We conclude that maternal chorioamnionitis is associ-
ated with an increase of early exhaled NO (nl/min/kg) in
mechanically ventilated preterm infants weighing
<2,000 g. Chorioamnionitis is also associated in the new-
born with an increase of C-reactive protein and of endo-
tracheal nitrites–nitrates levels but not of early IL-8.
Although an early single measurement of exhaled NO
has little clinical applicability as a marker of lung inflam-
mation, repeated measurements during the first days or
weeks of life when the infant is intubated and mechan-
ically ventilated showing increasing values may be useful
to suspect BPD. May et al.41 have shown that an increase
exhaled NO along the first 28 days of life was related to
BPD, and that there was a linear trend in exhaled NO
results as severity of BPD increased. In these circum-
stances, treatment could be prescribed to improve the
prognosis of this chronic lung disease.
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